(Q32119135)

6 July 2017

title

Non-peptide inhibitors of HCV serine proteinase (English)

1 reference

6 July 2017

Kakiuchi N

1

1 reference

6 July 2017

Komoda Y

2

1 reference

6 July 2017

Komoda K

3

1 reference

6 July 2017

Takeshita N

4

1 reference

6 July 2017

Okada S

5

1 reference

6 July 2017

Tani T

6

1 reference

6 July 2017

Shimotohno K

7

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 July 2017

1 reference

6 July 2017

volume

421

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

217-220

1 reference

Genetic organization and diversity of the hepatitis C virus

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

An enzyme-linked immunosorbent assay for detecting proteolytic activity of hepatitis C virus proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Cleavage activity of hepatitis C virus serine proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

Structure and organization of the hepatitis C virus genome isolated from human carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901566-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(97)01566-4

1 reference

6 July 2017

1 reference